Publication	Data		Fish	Anatomy
Wu et al., 2025	Fig. 1		atp7ahza4/hza4; vu19Tg (AB) ,   atp7ahza4/hza4 (AB)	central nervous system axon decreased branchiness, abnormal central nervous system axon decreased length, abnormal central nervous system axon extension decreased rate of occurrence, abnormal central nervous system collateral sprouting decreased occurrence, abnormal central nervous system DsRed2 expression decreased amount, abnormal central nervous system glioblast (sensu Vertebrata) olig2 expression decreased amount, abnormal central nervous system myelin sheath mbpa expression decreased amount, abnormal central nervous system myelin sheath plp1a expression decreased amount, abnormal central nervous system neuronal stem cell sox2 expression decreased amount, abnormal neuron regulation of membrane potential disrupted, abnormal spinal cord myelin sheath decondensed, abnormal spinal cord myelin sheath decreased thickness, abnormal
	Fig. 2		atp7ahza4/hza4 (AB)	central nervous system glioblast (sensu Vertebrata) tfr1a expression decreased amount, abnormal whole organism fth1a expression decreased amount, abnormal whole organism tfr1a expression decreased amount, abnormal whole organism iron atom increased amount, abnormal
	Fig. 3		atp7ahza4/hza4; vu19Tg (AB) ,   atp7ahza4/hza4 (AB)	central nervous system glioblast (sensu Vertebrata) Ab3-gpx4 labeling decreased amount, abnormal head Ab3-gpx4 labeling decreased amount, abnormal spinal cord apoptotic process increased occurrence, abnormal spinal cord membrane lipid catabolic process increased occurrence, abnormal whole organism Ab3-gpx4 labeling decreased amount, abnormal
	Fig. 4		atp7ahza4/hza4; vu19Tg (AB) ,   atp7ahza4/hza4 (AB)	central nervous system glioblast (sensu Vertebrata) Ab3-gpx4 labeling decreased amount, abnormal central nervous system myelin sheath mbpa expression decreased amount, abnormal central nervous system myelin sheath plp1a expression decreased amount, abnormal whole organism Ab3-gpx4 labeling decreased amount, abnormal whole organism malonaldehyde increased amount, abnormal whole organism membrane lipid catabolic process increased occurrence, abnormal
	Fig. 5		atp7ahza4/hza4; vu19Tg (AB) ,   atp7ahza4/hza4 (AB)	central nervous system glioblast (sensu Vertebrata) Ab3-gpx4 labeling decreased amount, abnormal central nervous system myelin sheath mbpa expression decreased amount, abnormal central nervous system myelin sheath plp1a expression decreased amount, abnormal whole organism Ab3-gpx4 labeling decreased amount, abnormal whole organism malonaldehyde increased amount, abnormal
Zhao et al., 2020	Fig. 7		atp7ahza4/hza4	retina mitochondrion swollen, abnormal whole organism atf6 expression increased amount, abnormal whole organism cox4i2 expression increased amount, abnormal whole organism eif2ak3 expression increased amount, abnormal whole organism ern1 expression increased amount, abnormal whole organism hmox2a expression increased amount, abnormal whole organism loxa expression increased amount, abnormal whole organism znrf2a expression increased amount, abnormal
Zhao et al., 2019	Fig. 6		atp7ahza4/hza4	intestinal epithelial cell endoplasmic reticulum loose, abnormal intestinal epithelial cell mitochondrial inner membrane swollen, abnormal intestine fabp2 expression decreased amount, abnormal intestine hspa5 expression increased amount, abnormal intestine slc15a1b expression decreased amount, abnormal whole organism cyp3a65 expression decreased amount, abnormal whole organism cyp8b1.1 expression decreased amount, abnormal whole organism fabp2 expression decreased amount, abnormal whole organism slc15a1b expression decreased amount, abnormal
Ackerman et al., 2018	Fig. 1		atp7agw71/gw71	retina copper-63 absent, abnormal
	Fig. 2		atp7agw71/gw71	kidney copper-63 increased amount, abnormal liver copper-63 decreased amount, abnormal midbrain copper-63 decreased amount, abnormal retinal outer nuclear layer copper-63 decreased amount, abnormal
	Fig. 3		atp7agw71/gw71	retinal outer nuclear layer copper-63 decreased amount, abnormal
	Fig. S3		atp7agw71/gw71	kidney copper-63 increased amount, abnormal nervous system copper-63 decreased amount, abnormal
Xiao et al., 2018	Fig. 2		atp7agw71/gw71	brain copper-63 decreased amount, abnormal
	Fig. 3		atp7agw71/gw71	circadian behavior process quality, abnormal regulation of locomotor rhythm process quality, abnormal startle response process quality, abnormal swimming behavior frequency, abnormal
	Fig. 5		atp7agw71/gw71	startle response process quality, abnormal
	Fig. 6		atp7agw71/gw71	norepinephrine biosynthetic process process quality, abnormal whole organism noradrenaline decreased amount, abnormal
Chen et al., 2011	Fig. 1		WT + MO1-atp7a ,   WT + MO1-atp7a + MO5-tp53	whole organism atp7a expression decreased amount, abnormal whole organism sod1 expression decreased amount, abnormal
	Fig. 3		WT + MO1-atp7a	whole organism sp1 expression decreased amount, abnormal
	Fig. 4		WT + MO1-atp7a	notochord development process quality, abnormal pigmentation process quality, abnormal
Madsen et al., 2008	Fig. 1		atp7agw71/+; atp7avu69/+ (AB)	pigmentation disrupted, abnormal
	Fig. 3		atp7agw71/gw71 (AB)	ossification increased magnitude, abnormal pigmentation disrupted, abnormal skeletal system morphology, abnormal
Madsen et al., 2008	Fig. 1		atp7aj246/j246 ,   atp7avu69/vu69 ,   atp7aj246/+; atp7avu69/+	fourth ventricle increased size, abnormal notochord morphology, abnormal pigmentation disrupted, abnormal
	Fig. 3		atp7avu69/vu69	notochord morphology, abnormal pigmentation disrupted, abnormal whole organism morphology, abnormal
Phenotype Annotation (1994-2006)	Fig. for (vu69)		atp7avu69/vu69	blood quality, abnormal heart quality, abnormal melanocyte intensity, abnormal midbrain hindbrain boundary quality, abnormal notochord undulate, abnormal pharyngeal arch 3-7 skeleton quality, abnormal